Felix W Frueh

发表

Strategic paths for biomarker qualification.

Federico M Goodsaid, Felix W Frueh, William Mattes, 2008, Toxicology.

Implementing the U.S. FDA guidance on pharmacogenomic data submissions

Felix W Frueh, Federico Goodsaid, F. Frueh, 2007, Environmental and molecular mutagenesis.

On rat poison and human medicines: personalizing warfarin therapy.

Felix W Frueh, F. Frueh, 2012, Trends in molecular medicine.

Back to the future: why randomized controlled trials cannot be the answer to pharmacogenomics and personalized medicine.

Felix W Frueh, F. Frueh, 2009, Pharmacogenomics.

The Predictive Safety Testing Consortium: A synthesis of the goals, challenges and accomplishments of the Critical Path.

Felix W Frueh, William Mattes, F. Frueh, 2007, Drug discovery today. Technologies.

Impact of Proton Pump Inhibitors on the Effectiveness of Clopidogrel After Coronary Stent Placement: The Clopidogrel Medco Outcomes Study

Felix W Frueh, Zeruesenay Desta, David A Flockhart, 2010, Pharmacotherapy.

QA/QC: challenges and pitfalls facing the microarray community and regulatory agencies

Weida Tong, Leming Shi, Hong Fang, 2004, Expert review of molecular diagnostics.

From pharmacogenetics to personalized medicine: a vital need for educating health professionals and the community.

Felix W Frueh, F. Frueh, D. Gurwitz, 2004, Pharmacogenomics.

Pharmacogenomics steps toward personalized medicine.

Felix W Frueh, F. Frueh, Hong-Guang Xie, 2005, Personalized medicine.

Impact of microarray data quality on genomic data submissions to the FDA

Felix W Frueh, F. Frueh, 2006, Nature Biotechnology.

Regulation, reimbursement, and the long road of implementation of personalized medicine--a perspective from the United States.

Felix W Frueh, F. Frueh, 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

An integrated bioinformatics infrastructure essential for advancing pharmacogenomics and personalized medicine in the context of the FDA's Critical Path Initiative.

Weida Tong, Leming Shi, Hong Fang, 2007, Drug discovery today. Technologies.